Archives: Press

Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections
Ohio is No. 2 state to start a business in 2025, according to new study
2025 STARTUPS TO WATCH
2024 Innovators In Healthcare And Life Sciences Awards
Venture capital firm Rev1 Ventures to create start-up space in Franklinton and OSU
Venture capital firm Rev1 Ventures to create start-up space in Franklinton and OSU
Clarametyx Bioscience Recognized as “Infectious Disease Innovation of the Year” In 2024 BioTech Breakthrough Awards
Prevedere is now part of the Board family – a quantum leap in enterprise planning!
Entrepreneur Reflects on Building Startups in Dublin